Key result
CV risk factor modification reduces dysrhythmia load as a key adjuvant therapy in AF.
Why the study?
Cardiovascular risk modification is overlooked as a key adjuvant treatment strategy alongside pharmacologic management and invasive procedures in AF.
Does a cardiovascular risk factor modification strategy reduce dysrhythmia load in patients with atrial fibrillation?
Does a cardiovascular risk factor modification strategy reduce dysrhythmia load in patients with atrial fibrillation?
Cardiovascular risk modification serves as a key adjuvant treatment strategy to reduce dysrhythmia load in patients with atrial fibrillation.
May support risk factor modification in AF management; hypothesis-generating pending higher-level evidence.
Atrial fibrillation (AF) is common, with many modifiable and nonmodifiable risk factors contributing to its increasing prevalence. Pharmacologic management and invasive procedures are the mainstays of treatment, but cardiovascular risk modification is overlooked as a key adjuvant treatment strategy. This article describes the clinical effects of implementing a risk factor modification strategy to reduce dysrhythmia load.
No takes yet. Share an insight, caveat, or question.
Maureen Knechtel (2023) conducted a review in Atrial fibrillation. Risk factor modification was evaluated. Implementing a cardiovascular risk factor modification strategy serves as a key adjuvant treatment to reduce dysrhythmia load in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: